Andrew T. Trueblood

Andrew T. Trueblood serves as an Acquisition Specialist at the Naval Health Research Center (N63116), where he plays a pivotal role in advancing the biomedical readiness of Navy and Marine Corps personnel through strategic procurement of cutting-edge medical technologies. Responsible for managing the full lifecycle of acquisitions—from requirements validation and market research to contract award and administration—he specializes in procuring innovative diagnostic tools, wearable biosensors, and biological product manufacturing capabilities critical to operational health surveillance. His work directly supports the Center’s mission to detect, monitor, and mitigate health threats in austere environments, ensuring that procurement aligns with rapid deployment and field-validation priorities. Trueblood cultivates collaborative relationships with a diverse range of vendors, including specialized biomanufacturers, biomedical engineering firms, and metal component suppliers capable of meeting stringent DoD performance and compliance standards. While no single contractor dominates his portfolio, he consistently engages with small and mid-sized enterprises possessing niche expertise in biosensor integration, sterile manufacturing, and ruggedized medical hardware. His approach emphasizes technical capability over scale, fostering partnerships with firms that can rapidly prototype and validate solutions under operational constraints. His contracting patterns reflect a balanced commitment to socioeconomic goals, with approximately half of his acquisitions set aside for small businesses under FAR 19.5, and the other half open to all competitors. This dual approach ensures both broad market competition and meaningful opportunities for small business innovation, particularly among firms certified under the SBA’s 8(a), HUBZone, or SDVOSB programs. Trueblood’s primary procurement focus centers on NAICS 325414 (Biological Product Manufacturing) and 332311 (Prefabricated Metal Building and Component Manufacturing), reflecting his dual emphasis on biological diagnostics and ruggedized infrastructure for field-deployable medical systems. He frequently acquires sterile bioreactors, pathogen detection kits, and modular, corrosion-resistant enclosures designed for expeditionary use, demonstrating deep technical fluency in both biomedical engineering and military-grade fabrication standards.